newsfilter
← Latest News
GlobeNewswire·

Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference

CARLSBAD, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that